Genetics of type 2 diabetes: the GWAS era and future perspectives [Review].
暂无分享,去创建一个
[1] D. Mccormick. Sequence the Human Genome , 1986, Bio/Technology.
[2] J. Lehmann,et al. An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*) , 1995, The Journal of Biological Chemistry.
[3] J. Lehmann,et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). , 1995, The Journal of biological chemistry.
[4] L. Groop,et al. Metabolic Consequences of a Family History of NIDDM (The Botnia Study): Evidence for Sex-Specific Parental Effects , 1996, Diabetes.
[5] P. Poulsen,et al. Heritability of Type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance – a population-based twin study , 1999, Diabetologia.
[6] E S Lander,et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. , 2000, Nature genetics.
[7] Eric S. Lander,et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes , 2000, Nature Genetics.
[8] T. Kadowaki,et al. The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 Diabetes , 2000 .
[9] Tom H. Lindner,et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus , 2000, Nature Genetics.
[10] T. Kadowaki,et al. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. , 2000, Biochemical and biophysical research communications.
[11] M. Kasuga,et al. The Pro12 -->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. , 2001, Diabetes.
[12] G I Bell,et al. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. , 2001, The New England journal of medicine.
[13] Timothy B. Stockwell,et al. The Sequence of the Human Genome , 2001, Science.
[14] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[15] J. Gulcher,et al. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. , 2003, American journal of human genetics.
[16] M. McCarthy,et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. , 2003, Diabetes.
[17] A. Hattersley,et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. , 2004, Diabetes.
[18] A. Favier,et al. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. , 2004, Diabetes.
[19] M. Olivier. A haplotype map of the human genome , 2003, Nature.
[20] Lu Qi,et al. Variant of Transcription Factor 7-Like 2 (TCF7L2) Gene and the Risk of Type 2 Diabetes in Large Cohorts of U.S. Women and Men , 2006, Diabetes.
[21] H. Stefánsson,et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.
[22] David M Nathan,et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. , 2006, The New England journal of medicine.
[23] K. Silver,et al. Polymorphisms in the Transcription Factor 7-Like 2 (TCF7L2) Gene Are Associated With Type 2 Diabetes in the Amish , 2006, Diabetes.
[24] Steven Wiltshire,et al. Association Analysis of 6,736 U.K. Subjects Provides Replication and Confirms TCF7L2 as a Type 2 Diabetes Susceptibility Gene With a Substantial Effect on Individual Risk , 2006, Diabetes.
[25] Kristin G Ardlie,et al. Common Single Nucleotide Polymorphisms in TCF7L2 Are Reproducibly Associated With Type 2 Diabetes and Reduce the Insulin Response to Glucose in Nondiabetic Individuals , 2006, Diabetes.
[26] Laura J. Scott,et al. Association of Transcription Factor 7-Like 2 (TCF7L2) Variants With Type 2 Diabetes in a Finnish Sample , 2006, Diabetes.
[27] P. Froguel,et al. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population , 2007, Diabetologia.
[28] D. Melzer,et al. A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses. , 2006, American journal of human genetics.
[29] R. Scharfmann,et al. Transcription Factor TCF7L2 Genetic Study in the French Population , 2006, Diabetes.
[30] J. Gulcher,et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes , 2007, Nature Genetics.
[31] M. McCarthy,et al. Common variants in WFS1 confer risk of type 2 diabetes , 2007, Nature Genetics.
[32] T. Hudson,et al. A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.
[33] P. Froguel,et al. Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population , 2007, Diabetologia.
[34] M. McCarthy,et al. Common Variants of the Novel Type 2 Diabetes Genes CDKAL1 and HHEX/IDE Are Associated With Decreased Pancreatic β-Cell Function , 2007, Diabetes.
[35] M. McCarthy,et al. Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes , 2007, Science.
[36] Y. Iwamoto,et al. Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population , 2007, Diabetologia.
[37] D. Gudbjartsson,et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes , 2007, Nature Genetics.
[38] T. Hansen,et al. Studies of Association of Variants Near the HHEX, CDKN2A/B, and IGF2BP2 Genes With Type 2 Diabetes and Impaired Insulin Release in 10,705 Danish Subjects , 2007, Diabetes.
[39] H. Shiota,et al. SNPs in the KCNJ11-ABCC8 gene locus are associated with type 2 diabetes and blood pressure levels in the Japanese population , 2007, Journal of Human Genetics.
[40] Kristin G Ardlie,et al. Evaluation of Common Variants in the Six Known Maturity-Onset Diabetes of the Young (MODY) Genes for Association With Type 2 Diabetes , 2007, Diabetes.
[41] Marcia M. Nizzari,et al. Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.
[42] N. Stefan,et al. Polymorphisms within Novel Risk Loci for Type 2 Diabetes Determine β-Cell Function , 2007, PloS one.
[43] K. Taylor,et al. Genome-Wide Association , 2007, Diabetes.
[44] G. Abecasis,et al. A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2007, Science.
[45] D. Lawlor,et al. Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. , 2008, The Journal of clinical investigation.
[46] Jean Tichet,et al. A Polymorphism Within the G6PC2 Gene Is Associated with Fasting Plasma Glucose Levels , 2008, Science.
[47] M. McCarthy,et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges , 2008, Nature Reviews Genetics.
[48] L. Groop,et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus , 2008, Nature Genetics.
[49] M. McCarthy,et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes , 2008, Nature Genetics.
[50] T. Sanke,et al. Polymorphisms in the IDE-KIF11-HHEX gene locus are reproducibly associated with type 2 diabetes in a Japanese population. , 2008, The Journal of clinical endocrinology and metabolism.
[51] E. Kang,et al. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population , 2008, Journal of Human Genetics.
[52] K. Mossman. The Wellcome Trust Case Control Consortium, U.K. , 2008 .
[53] Nicholette D. Palmer,et al. Quantitative Trait Analysis of Type 2 Diabetes Susceptibility Loci Identified From Whole Genome Association Studies in the Insulin Resistance Atherosclerosis Family Study , 2008, Diabetes.
[54] F. Zhang,et al. A common variant in the FTO gene is associated with obesity in the Uyghur population , 2008, Journal of endocrinological investigation.
[55] Yusuke Nakamura,et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 With Susceptibility to Type 2 Diabetes in a Japanese Population , 2008, Diabetes.
[56] T. Hansen,et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations , 2008, Nature Genetics.
[57] Mark I. McCarthy,et al. Assessing the Combined Impact of 18 Common Genetic Variants of Modest Effect Sizes on Type 2 Diabetes Risk , 2008, Diabetes.
[58] Peter Almgren,et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. , 2008, The New England journal of medicine.
[59] R. D'Agostino,et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. , 2008, The New England journal of medicine.
[60] M. Kasuga,et al. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. , 2008, The Journal of clinical endocrinology and metabolism.
[61] Weiping Jia,et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. , 2009, JAMA.
[62] D. Altshuler,et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion , 2009, Nature Genetics.
[63] Jean Tichet,et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia , 2009, Nature Genetics.
[64] J. Chan,et al. Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of the association , 2009, Journal of Human Genetics.
[65] Zhuoyou Chen,et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes in the population of mainland China , 2009, Diabetologia.
[66] E. Tai,et al. Genetic Variation in KCNQ1 Associates With Fasting Glucose andβ-Cell Function , 2009, Diabetes.
[67] J. Florez,et al. The clinical application of genetic testing in type 2 diabetes: a patient and physician survey , 2009, Diabetologia.
[68] E. Tai,et al. Genetic variation in KCNQ1 associates with fasting glucose and beta-cell function: a study of 3,734 subjects comprising three ethnicities living in Singapore. , 2009, Diabetes.
[69] Inês Barroso,et al. Variants in MTNR1B influence fasting glucose levels , 2009, Nature Genetics.
[70] P. Elliott,et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk , 2009, Nature Genetics.
[71] K. Xiang,et al. Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population , 2009, Diabetologia.
[72] P. Elliott,et al. Genetic Variant in HK1 Is Associated With a Proanemic State and A1C but Not Other Glycemic Control–Related Traits , 2009, Diabetes.
[73] Ayellet V. Segrè,et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.
[74] S. Humphries,et al. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study , 2010, BMJ : British Medical Journal.
[75] Christian Gieger,et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.
[76] Richard W. Grant,et al. Genetic Risk Reclassification for Type 2 Diabetes by Age Below or Above 50 Years Using 40 Type 2 Diabetes Risk Single Nucleotide Polymorphisms , 2010, Diabetes Care.
[77] Fuu-Jen Tsai,et al. A Genome-Wide Association Study Identifies Susceptibility Variants for Type 2 Diabetes in Han Chinese , 2010, PLoS genetics.
[78] 大森 慎太郎. Replication study for the association of new meta-analysis-derived risk loci with susceptibility to type 2 diabetes in 6,244 Japanese individuals , 2010 .
[79] Y. J. Kim,et al. Identification of New Genetic Risk Variants for Type 2 Diabetes , 2010, PLoS genetics.
[80] Alex Doney,et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge , 2010, Nature Genetics.
[81] K. Kohara,et al. The GCKR rs780094 polymorphism is associated with susceptibility of type 2 diabetes, reduced fasting plasma glucose levels, increased triglycerides levels and lower HOMA-IR in Japanese population , 2010, Journal of Human Genetics.
[82] D. Altshuler,et al. A map of human genome variation from population-scale sequencing , 2010, Nature.
[83] T. Hansen,et al. The diabetogenic VPS13C/C2CD4A/C2CD4B rs7172432 variant impairs glucose-stimulated insulin response in 5,722 non-diabetic Danish individuals , 2011, Diabetologia.
[84] Yusuke Nakamura,et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B , 2010, Nature Genetics.
[85] Peter Donnelly,et al. Edinburgh Research Explorer Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes , 2022 .
[86] E. Lander. Initial impact of the sequencing of the human genome , 2011, Nature.
[87] M. Guyer,et al. Charting a course for genomic medicine from base pairs to bedside , 2011, Nature.